Luciana Pinto Valadares
Overview
Explore the profile of Luciana Pinto Valadares including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Valadares L, de Carvalho D
J Clin Res Pediatr Endocrinol
. 2023 Sep;
PMID: 37680384
Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) is a rare FGF23-independent disorder caused by biallelic variants in the gene. The disease severity varies, and patients have an increased risk of developing...
2.
Miranda I, Valadares L, Barra G, Mesquita P, Bandeira de Santana L, de Castro L, et al.
Front Endocrinol (Lausanne)
. 2023 Mar;
14:1117873.
PMID: 36967793
Objective: Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant syndrome characterized by its clinical variability and complexity in diagnosis and treatment. We performed both clinical and molecular descriptions...
3.
Jacques J, Valadares L, Moura A, Oliveira M, Naves L
Front Endocrinol (Lausanne)
. 2023 Mar;
14:1091185.
PMID: 36875457
Objective: To describe the frequency of hypophysitis and hypopituitarism in cancer patients who are undergoing antineoplastic treatment with immunotherapy, as well as to describe the clinical, epidemiological, and demographic characteristics...
4.
Valadares L, Ferreira B, Matos da Cunha B, Moreira L, Batista F, da Fonseca Hottz C, et al.
Arch Endocrinol Metab
. 2022 Apr;
66(2):247-255.
PMID: 35420267
Objective: Fibrous dysplasia (FD) is a rare bone disorder that can involve any part of the skeleton, leading to bone pain, deformities, and fractures. Treatment with intravenous bisphosphonates has been...
5.
Valadares L, Meireles C, de Toledo I, Santarem de Oliveira R, de Castro L, Abreu A, et al.
J Endocr Soc
. 2019 May;
3(5):979-995.
PMID: 31041429
mutations represent the most common genetic cause of central precocious puberty (CPP) but associations between genotype and clinical features have not been extensively explored. This systematic review and meta-analysis investigated...
6.
Valadares L, Pfeilsticker A, de Brito Sousa S, Cardoso S, de Moraes O, de Castro L, et al.
Endocrine
. 2018 Sep;
62(2):326-332.
PMID: 30242600
Purpose: 11β-hydroxylase deficiency accounts for 5% of congenital adrenal hyperplasia cases. Diagnosis suspiction is classically based on the association between abnormal virilization, precocious puberty, and hypertension in 46XX or 46XY...